TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p

✍ Scribed by Jasek, M; Gondek, L P; Bejanyan, N; Tiu, R; Huh, J; Theil, K S; O'Keefe, C; McDevitt, M A; Maciejewski, J P

• Book ID: 109886939
• Publisher: Nature Publishing Group
• Year: 2009
• Tongue: English
• Weight: 190 KB
• Volume: 24
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/leu.2009.189